ES449456A1 - Procedimiento para la preparacion de nuevos pseudotrisacari-dos. - Google Patents
Procedimiento para la preparacion de nuevos pseudotrisacari-dos.Info
- Publication number
- ES449456A1 ES449456A1 ES449456A ES449456A ES449456A1 ES 449456 A1 ES449456 A1 ES 449456A1 ES 449456 A ES449456 A ES 449456A ES 449456 A ES449456 A ES 449456A ES 449456 A1 ES449456 A1 ES 449456A1
- Authority
- ES
- Spain
- Prior art keywords
- gentamicin
- antibiotic
- translation
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 Vedamicin Chemical compound 0.000 abstract 3
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 abstract 3
- 230000003115 biocidal effect Effects 0.000 abstract 2
- LKKVGKXCMYHKSL-LLZRLKDCSA-N gentamycin A Chemical compound O[C@H]1[C@H](NC)[C@@H](O)CO[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N LKKVGKXCMYHKSL-LLZRLKDCSA-N 0.000 abstract 2
- URWAJWIAIPFPJE-VHLNBGGKSA-N (2r,3r,4r,5r)-2-[(1s,2r,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-VHLNBGGKSA-N 0.000 abstract 1
- CEAZRRDELHUEMR-CAMVTXANSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-CAMVTXANSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-BSBKYKEKSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-BSBKYKEKSA-N 0.000 abstract 1
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 abstract 1
- ABCLPPNEPBAKRL-ROQIPNNMSA-N (2r,3s,4s,5r,6s)-2-[(1r)-1-aminoethyl]-6-[(1r,2r,3s,4r,6s)-4,6-diamino-3-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)O)[C@@H](N)C[C@H]1N ABCLPPNEPBAKRL-ROQIPNNMSA-N 0.000 abstract 1
- YQGZDAPJXRYYLX-ZFAMMYHGSA-N Antibiotic JI-20A Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N YQGZDAPJXRYYLX-ZFAMMYHGSA-N 0.000 abstract 1
- WYJSPPYVEJPMJA-DJWUNRQOSA-N Antibiotic JI-20B Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)N)[C@@H](N)C[C@H]1N WYJSPPYVEJPMJA-DJWUNRQOSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- DNYGXMICFMACRA-XHEDQWPISA-N Gentamicin C2b Chemical compound O1[C@H](CNC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N DNYGXMICFMACRA-XHEDQWPISA-N 0.000 abstract 1
- HFLKNINDVFJPQT-UHFFFAOYSA-N Gentamicin X2 Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)N)C(N)CC1N HFLKNINDVFJPQT-UHFFFAOYSA-N 0.000 abstract 1
- HFLKNINDVFJPQT-ZFAMMYHGSA-N Gentamicin X2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N HFLKNINDVFJPQT-ZFAMMYHGSA-N 0.000 abstract 1
- ZWWVMGQAOAIIQO-UHFFFAOYSA-N Mutamicin 2 Natural products CNC1C(O)C(OC2CC(OC3OC(=CCC3N)CN)C(N)CC2N)OCC1(C)O ZWWVMGQAOAIIQO-UHFFFAOYSA-N 0.000 abstract 1
- GCLCARAXIXZEAH-UHFFFAOYSA-N Mutamicin 4 Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)C(O)C1N GCLCARAXIXZEAH-UHFFFAOYSA-N 0.000 abstract 1
- UTHKVKLHMFIYMO-UHFFFAOYSA-N Mutamicin 5 Natural products CNC1C(O)C(OC2C(N)CC(N)C(OC3OC(=CCC3N)CN)C2N)OCC1(C)O UTHKVKLHMFIYMO-UHFFFAOYSA-N 0.000 abstract 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- RHRAMPXHWHSKQB-GGEUKFTFSA-N betamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1N RHRAMPXHWHSKQB-GGEUKFTFSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- RHRAMPXHWHSKQB-UHFFFAOYSA-N gentamicin B Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CN)O2)O)C(N)CC1N RHRAMPXHWHSKQB-UHFFFAOYSA-N 0.000 abstract 1
- 229930076781 gentamycin C1 Natural products 0.000 abstract 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-JYDJLPLMSA-N gentamycin C2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-JYDJLPLMSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229960004744 micronomicin Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
- 125000003944 tolyl group Chemical group 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento para la preparación de nuevos -pscudotrisacáridos, particularmente derivados sustituidos en 1-N de los 4,6-di-(aminoglicosi)-1,3-diamino-ciclitoles gentamicina A, gentamicina B, gentamicina B1, gentamicina C1, gentamicina C1a, gentamicina C2, gentamicina C2a, gentamicina C2b, gentamicina X2, sisomicina, vedamicina, tobramicina, Antibiótico G-418, Antibiótico 66-40B, Antibiótico 66-40D, Antibiótico JI-20A, Antibiótico JI-20B, Antibiótico G-52, mutamicina 1, mutamicina 2, mutamicina 4, mutamicina 5 y mutamicina 6, en que el sustituyente es -CH2X, siendo X hidrógeno, alcohilo, alquenilo, cicloalcohilo, cicloalcohilaminoalcohilo, aminohidroxialcohilo, N-alcohilaminohidroxialcohilo, fenilo, bencilo o tolilo dichos radicales alifáticos hasta siete átomos de carbono.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45260074A | 1974-03-19 | 1974-03-19 | |
| CH1060274A CH606076A5 (es) | 1973-08-06 | 1974-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES449456A1 true ES449456A1 (es) | 1978-03-01 |
Family
ID=25706976
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES428892A Expired ES428892A1 (es) | 1974-03-19 | 1974-08-02 | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. |
| ES449456A Expired ES449456A1 (es) | 1974-03-19 | 1976-07-01 | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES428892A Expired ES428892A1 (es) | 1974-03-19 | 1974-08-02 | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. |
Country Status (1)
| Country | Link |
|---|---|
| ES (2) | ES428892A1 (es) |
-
1974
- 1974-08-02 ES ES428892A patent/ES428892A1/es not_active Expired
-
1976
- 1976-07-01 ES ES449456A patent/ES449456A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES428892A1 (es) | 1977-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU526697B2 (en) | Novel heterocyclic compounds, process fur preparing them and medical compositions containing them | |
| YU175791A (sh) | Heterociklični derivati monocikličnih beta laktam antibiotika | |
| NO961356L (no) | Antracyklinonderivater, samt anvendelse derav ved amyloidose | |
| GB1446980A (en) | A-aminooxy-carboxylic acid hydrazides | |
| ES448421A1 (es) | Procedimiento para la preparacion de compuestos de rifamici-na de elevada actividad antibiotica. | |
| ES8800360A1 (es) | Procedimiento para la produccion de glicopeptidos y -o oligosacaridos | |
| ES462305A1 (es) | Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos. | |
| ES411038A1 (es) | Un procedimiento para la preparacion de compuestos semisin-teticos intermedios en la produccion de cefalosporinas, pe- nicilinas y antibioticos relacionados de beta-lactama. | |
| ES420412A1 (es) | Un procedimiento para preparar una 1-piperinsulfonilurea. | |
| ES428712A1 (es) | Procedimiento para la preparacion de fenilureas sibstituidas. | |
| ES419264A1 (es) | Un procedimiento para la preparacion de derivados de azeti-din-2-ona. | |
| ES436569A1 (es) | Procedimiento para la produccion de compuestos heterocicli- cos. | |
| ES482506A1 (es) | Procedimiento para la obtencion de compuestos derivados de gentamicina. | |
| ES428892A1 (es) | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. | |
| MX161272A (es) | Procedimiento para preparar derivados de flavanona | |
| DK139102B (da) | Fremgangsmåde til fremstilling af et antibioticum, kaldet forbindelse 38 295, eller salte heraf. | |
| GB1504832A (en) | Gentamicin derivatives and methods of production thereof | |
| ES480920A1 (es) | Procedimiento para preparar antibioticos de cefalosporina. | |
| ES405281A1 (es) | Un procedimiento para preparar nuevos compuestos de cefa- losporina. | |
| ES332535A1 (es) | Un metodo para preparar una composicion antibacteriana eficaz contra las bacterias gram-positivas y gram-negativas. | |
| ES209472U (es) | Boveda para horno. | |
| ES437846A1 (es) | Un procedimiento para la obtencion de nuevos derivados de difenilalilaminoalcanol. | |
| ES8407494A1 (es) | Procedimiento para preparar el antibiotico cefuroxima. | |
| ES374266A1 (es) | Procedimiento para la obtencion de derivados de piridina sulfurosos. | |
| ES471792A1 (es) | Un procedimiento para prepara un compuesto de 2-azetidinona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19971229 |